PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.33%
Revenue growth under 50% of LSCC's 0.83%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-1.92%
Negative gross profit growth while LSCC is at 1.65%. Joel Greenblatt would examine cost competitiveness or demand decline.
-542.50%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-231.58%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-293.42%
Negative net income growth while LSCC stands at 0.96%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-274.42%
Negative EPS growth while LSCC is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-274.42%
Negative diluted EPS growth while LSCC is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.10%
Share reduction more than 1.5x LSCC's 0.35%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-2.51%
Reduced diluted shares while LSCC is at 0.35%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
2.32%
Dividend growth of 2.32% while LSCC is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-7.27%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-52.53%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
53.71%
10Y revenue/share CAGR under 50% of LSCC's 522.98%. Michael Burry would suspect a lasting competitive disadvantage.
11.08%
5Y revenue/share CAGR under 50% of LSCC's 101.61%. Michael Burry would suspect a significant competitive gap or product weakness.
3.47%
3Y revenue/share CAGR under 50% of LSCC's 16.27%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
12095.78%
5Y OCF/share CAGR above 1.5x LSCC's 39.44%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-44.04%
Negative 3Y OCF/share CAGR while LSCC stands at 39.55%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-937.41%
Negative 10Y net income/share CAGR while LSCC is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1.99%
Negative 5Y net income/share CAGR while LSCC is 191.99%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-193.53%
Negative 3Y CAGR while LSCC is 40.43%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
50.55%
Below 50% of LSCC's 253.56%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
66.64%
Below 50% of LSCC's 133.97%. Michael Burry suspects a serious short-term disadvantage in building book value.
108.73%
Dividend/share CAGR of 108.73% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-69.20%
Negative 5Y dividend/share CAGR while LSCC stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
33.29%
3Y dividend/share CAGR of 33.29% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
10.02%
AR growth is negative/stable vs. LSCC's 24.54%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-13.16%
Inventory is declining while LSCC stands at 5.19%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.42%
Asset growth above 1.5x LSCC's 1.81%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-3.93%
We have a declining book value while LSCC shows 3.46%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
44.26%
Debt growth of 44.26% while LSCC is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
90.64%
R&D growth drastically higher vs. LSCC's 1.47%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-2.24%
We cut SG&A while LSCC invests at 3.80%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.